Kymera Therapeutics to Participate in Upcoming September Investor Conferences
Kymera Therapeutics plans a series of webcast investor presentations at major healthcare and biopharma conferences throughout September 2026.
Rhea-AI Summary
Kymera Therapeutics (KYMR) will participate in several investor conferences in September 2026, including events hosted by Wells Fargo, Citi, H.C. Wainwright, Morgan Stanley and Stifel, with scheduled fireside chats and presentations across September 9–24.
Live webcasts and subsequent replays will be accessible via the Investors “News and Events” section of the company’s website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Sep 01 | Investor presentations | Positive | +0.2% | Conference presentations on KT-621 data at ERS and EADV congresses. |
| Aug 05 | 2Q26 earnings | Positive | +1.0% | Collaboration revenue, lower net loss, cash balance, and pipeline progress were reported. |
| Jul 28 | Earnings scheduling | Neutral | -0.9% | Company scheduled Q2 2026 results and webcast for August 5. |
| Jul 27 | CMO appointment | Neutral | -3.5% | Terence Rooney became CMO as Jared Gollob transitioned to advisor. |
| Jul 07 | Program appointment | Positive | +3.9% | Elizabeth Laws joined to lead KT-621 global program strategy. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were mixed, with positive responses to earnings and pipeline-related announcements but negative responses to a scheduling notice and leadership transition.
Key Terms
small molecule degrader technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats and presentations at the following upcoming investor events:
- Wells Fargo 21st Annual Healthcare Conference in Boston, MA on September 9 at 8:00 AM ET;
- Citi 2026 Biopharma Back to School Summit in New York, NY on September 10 at 11:20 AM ET;
- H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on September 14 at 4:30 PM ET;
- Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY on September 15 at 7:45 AM ET; and
- Stifel 2026 Virtual Immunology and Inflammation Forum on September 24 at 11:00 AM ET.
Live webcasts of the events will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X or LinkedIn.
Investor Contact:
Justine Koenigsberg
investors@kymeratx.com
857-285-5300
Media Contact:
Matthew Henson
media@kymeratx.com
857-285-5300
FAQ
What investor conferences will Kymera Therapeutics (KYMR) attend in September 2026?
Kymera Therapeutics will attend the Wells Fargo 21st Annual Healthcare Conference, Citi 2026 Biopharma Back to School Summit, H.C. Wainwright 28th Annual Global Investment Conference, Morgan Stanley 24th Annual Global Healthcare Conference, and the Stifel 2026 Virtual Immunology and Inflammation Forum.
When is Kymera Therapeutics presenting at the Wells Fargo Healthcare Conference in 2026?
Kymera Therapeutics is scheduled to participate at the Wells Fargo 21st Annual Healthcare Conference in Boston, Massachusetts on September 9 at 8:00 AM ET.
What is the date and time of Kymera Therapeutics’ session at the Citi 2026 Biopharma Back to School Summit?
Kymera Therapeutics plans to present at the Citi 2026 Biopharma Back to School Summit in New York, New York on September 10 at 11:20 AM ET.
When will Kymera Therapeutics present at the H.C. Wainwright 28th Annual Global Investment Conference?
Kymera Therapeutics is scheduled for a session at the H.C. Wainwright 28th Annual Global Investment Conference in New York, New York on September 14 at 4:30 PM ET.
What is the schedule for Kymera Therapeutics at the Morgan Stanley Global Healthcare Conference 2026?
Kymera Therapeutics expects to participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York, New York on September 15 at 7:45 AM ET.
When is Kymera Therapeutics presenting at the Stifel 2026 Virtual Immunology and Inflammation Forum?
Kymera Therapeutics is slated to present at the Stifel 2026 Virtual Immunology and Inflammation Forum on September 24 at 11:00 AM ET.
How can investors access Kymera Therapeutics’ September 2026 conference webcasts and replays?
Live webcasts of Kymera Therapeutics’ September 2026 conference appearances, along with archived replays, will be available in the Investors section of the company’s website under the “News and Events” page.